New IBS diagnosis · Condition program
New IBS diagnosis, a clear plan from day one.
Helps newly diagnosed patients understand IBS, find their triggers and start first-line diet and lifestyle care between visits.
- 12 weeks
- Base · free for providers
- Pro · patient upgrade
What’s included
Everything in the program, Base and Pro.
For: Adults newly diagnosed with irritable bowel syndrome (IBS-C, IBS-D or IBS-M) by their GI clinician.
| Included in the program | BaseFree to refer | ProPatient upgrade |
|---|---|---|
| IBS explained: gut–brain interaction, subtypes and what to expect | Included | Included |
| Diet guidance: soluble fiber, regular meals and when a low-FODMAP trial may help | Included | Included |
| FAQs on symptoms, stress, sleep and medications | Included | Included |
| AI Q&A, answered from your practice’s approved guidance | Included | Included |
| Escalation of red-flag symptoms to your practice | Included | Included |
| Progress updates to your practice | Included | Included |
| Daily symptom and stool-form tracking with coaching | Not included | Included |
| A guided low-FODMAP trial: restriction, reintroduction and personalization | Not included | Included |
| Habit building for meals, sleep, activity and stress | Not included | Included |
| Brain–gut behavioral exercises, such as CBT-based skills and relaxation | Not included | Included |
| Thesis NP check-ins when symptoms are not improving | Not included | Included |
Program goals
- Understand IBS as a common, real disorder of gut–brain interaction
- Identify personal symptom patterns and triggers
- Start first-line diet and lifestyle measures safely
- Know which symptoms need a clinician right away
Who acts on escalations
- Base: red flags go straight back to your practice, with the patient’s report and context.
- Pro: Thesis nurse practitioners can also step in, and your practice is kept informed.
- Agents never diagnose, prescribe or change a treatment plan.
How it engages patients
One stage at a time, always on protocol.
Over 12 weeks, each stage sends the right information at the right moment, answers questions from your practice’s guidance and records what your team needs to know.
Welcome and diagnosis explainedA plain-language introduction to IBS, the patient’s subtype and the plan their clinician set.
RecordedEducation delivered · IBS basics read
Clinical foundation
Guideline-based care, adapted to your practice.
Program content is built on published guidelines and reviewed by our clinical team. Your practice’s own protocols always take precedence.
A positive diagnosis, not a diagnosis of exclusion
ACG recommends a positive diagnostic strategy using the Rome IV criteria rather than exhaustive testing to exclude other causes. Education starts from that confident diagnosis, which helps patients accept it and engage with care.
[1] ACG 2021[5] Rome IVSoluble fiber first
Soluble, not insoluble, fiber is recommended to relieve global IBS symptoms. The program introduces it gradually to limit gas and bloating.
[1] ACG 2021A limited low-FODMAP trial, then reintroduction
Guidelines support a limited trial of a low-FODMAP diet, ideally with dietitian guidance, followed by structured reintroduction rather than long-term restriction.
[1] ACG 2021[4] AGA 2022Brain–gut behavioral therapy
Gut-directed psychotherapies, including cognitive behavioral therapy and gut-directed hypnotherapy, are recommended for global IBS symptoms. Pro includes skills-based exercises and points patients to formal therapy.
[1] ACG 2021Medication follows the subtype
Medication choices for IBS-C and IBS-D follow AGA guidelines. The program answers questions and supports adherence, but never starts or changes a medication.
[2] AGA 2022[3] AGA 2022
When we escalate to your practice
- Unintentional weight loss
- Rectal bleeding or black stools
- Symptoms that wake the patient at night
- Fever, or severe or worsening abdominal pain
- Persistent vomiting
- New symptoms that don’t fit IBS, or no improvement by week 8
What your practice receives
- Confirmation when the patient enrolls
- Progress summaries at key milestones and before follow-up visits
- Real-time escalation for any red-flag symptom
- Pro status, so you know when Thesis nurse practitioners are supporting a patient
Sources
- 1American College of GastroenterologyLacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17–44.
- 2American Gastroenterological AssociationLembo A, Sultan S, Chang L, et al. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea. Gastroenterology. 2022;163(1):137–151.
- 3American Gastroenterological AssociationChang L, Sultan S, Lembo A, et al. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation. Gastroenterology. 2022;163(1):118–136.
- 4American Gastroenterological AssociationChey WD, Hashash JG, Manning L, Chang L. AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review. Gastroenterology. 2022;162(6):1737–1745.
- 5Rome FoundationLacy BE, Mearin F, Chang L, et al. Bowel Disorders. Gastroenterology. 2016;150(6):1393–1407.
Guidelines inform program defaults. They do not replace clinical judgment, and patients are always directed to their own care team for diagnosis and treatment decisions.